Cargando…
P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431265/ http://dx.doi.org/10.1097/01.HS9.0000848076.05525.5e |
| _version_ | 1784780006104236032 |
|---|---|
| author | Wiestner, A. Baskar, S. Peng, H. Gaglione, E. Lindorfer, M. Taylor, R. Rader, C. |
| author_facet | Wiestner, A. Baskar, S. Peng, H. Gaglione, E. Lindorfer, M. Taylor, R. Rader, C. |
| author_sort | Wiestner, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312652022-08-31 P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS Wiestner, A. Baskar, S. Peng, H. Gaglione, E. Lindorfer, M. Taylor, R. Rader, C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431265/ http://dx.doi.org/10.1097/01.HS9.0000848076.05525.5e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Wiestner, A. Baskar, S. Peng, H. Gaglione, E. Lindorfer, M. Taylor, R. Rader, C. P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS |
| title | P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS |
| title_full | P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS |
| title_fullStr | P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS |
| title_full_unstemmed | P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS |
| title_short | P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS |
| title_sort | p1303: potentiating anti-cd20 monoclonal antibody therapy by targeting complement c3 activation fragments covalently deposited on lymphoma cells |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431265/ http://dx.doi.org/10.1097/01.HS9.0000848076.05525.5e |
| work_keys_str_mv | AT wiestnera p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells AT baskars p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells AT pengh p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells AT gaglionee p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells AT lindorferm p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells AT taylorr p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells AT raderc p1303potentiatinganticd20monoclonalantibodytherapybytargetingcomplementc3activationfragmentscovalentlydepositedonlymphomacells |